ISMPP is honored to have the opportunity to sponsor the next iteration of the Good Publication Practice (GPP) guidelines, an industry-leading document to guide the ethical development of medical publications. Development of the GPP4 guidelines is now well underway,...
Leanne Larson, MHA, Corporate Vice President and Worldwide Head, Real-World Evidence, Parexel International, USA* Interviewed by Sally Hassan, PhD, ISMPP CMPP™, Parexel International, UK. * The opinions expressed within are the author’s own and do not necessarily...
Daniel R. Pascheles, PhD, Molekule Consulting LLC, Miami, FL, USA; Claudia A. Piano, ISMPP CMPP™, CMC Connect, McCann Health Medical Communications, Radnor, PA, USA As medical affairs and medical publication professionals, it is important to understand how competitive...
Open Pharma recently released its Position Statement on Open Access, which advocates that access to pharmaceutical company-funded research should not be restricted by journal paywalls. The Position Statement points out that approximately half of all biomedical...
Challenges with authorship of industry-sponsored publications persist despite established guidelines and recommendations (International Committee of Medical Journal Editors [ICMJE] recommendations, Good Publication Practice 3 [GPP3] guidelines). While adherence to the...
